{"id":"https://openalex.org/W2136293754","doi":"https://doi.org/10.1158/1078-0432.ccr-11-0184","title":"Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients","display_name":"Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-01","ids":{"openalex":"https://openalex.org/W2136293754","doi":"https://doi.org/10.1158/1078-0432.ccr-11-0184","mag":"2136293754","pmid":"https://pubmed.ncbi.nlm.nih.gov/21586625"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-11-0184","doi":"https://doi.org/10.1158/1078-0432.ccr-11-0184","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-0184","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/17/13/4568/2300086/4568.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2136293754"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/17/13/4568/2300086/4568.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057516617","display_name":"Jon Amund Kyte","orcid":"https://orcid.org/0000-0002-2854-3694","observed_orcids":["https://orcid.org/0000-0002-2854-3694"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jon Amund Kyte","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003293427","display_name":"Gustav Gaudernack","orcid":"https://orcid.org/0000-0002-9678-7447","observed_orcids":["https://orcid.org/0000-0002-9678-7447"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gustav Gaudernack","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056318188","display_name":"Svein Dueland","orcid":"https://orcid.org/0000-0002-6125-6689","observed_orcids":["https://orcid.org/0000-0002-6125-6689"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Svein Dueland","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]},{"raw_affiliation_string":"Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106085662","display_name":"Sissel Trachsel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sissel Trachsel","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]},{"raw_affiliation_string":"Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005004003","display_name":"Lars Julsrud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Julsrud","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]},{"raw_affiliation_string":"Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071545176","display_name":"Steinar Aamdal","orcid":"https://orcid.org/0000-0001-8594-4868","observed_orcids":["https://orcid.org/0000-0001-8594-4868"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steinar Aamdal","raw_affiliation_strings":["Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Section for Clinical Cancer Research, Department of Oncology and 2Department of Radiology, Oslo University Hospital; 3Department of Immunology, Cancer Research Institute, Oslo University Hospital and University of Oslo; and 4Faculty of Medicine, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5057516617"],"corresponding_institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"],"apc_list":null,"apc_paid":null,"fwci":4.4006,"has_fulltext":true,"cited_by_count":117,"citation_normalized_percentile":{"value":0.95082984,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"17","issue":"13","first_page":"4568","last_page":"4580"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.043299999088048935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gv1001","display_name":"GV1001","score":0.9990000128746033},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.996999979019165},{"id":"https://openalex.org/keywords/stage-iv-melanoma","display_name":"stage IV melanoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4410000145435333},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.7110000252723694},{"id":"https://openalex.org/keywords/t-cell-memory","display_name":"T cell memory","score":0.8479999899864197},{"id":"https://openalex.org/keywords/ifn-gamma-il-10-ratio","display_name":"IFN-\u03b3/IL-10 ratio","score":0.8920000195503235},{"id":"https://openalex.org/keywords/cytokine-profile","display_name":"cytokine profile","score":0.7919999957084656},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.4000000059604645},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7806017398834229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7770359516143799},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5817572474479675},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5017390251159668},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4786621034145355},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46225637197494507},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46085137128829956},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45807382464408875},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.4388570785522461},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4382016956806183},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4321359395980835},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4234501123428345},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40846341848373413},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36100083589553833},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1328367292881012}],"mesh":[{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007156","descriptor_name":"Immunologic Memory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019098","descriptor_name":"Telomerase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-11-0184","doi":"https://doi.org/10.1158/1078-0432.ccr-11-0184","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-0184","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/17/13/4568/2300086/4568.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:21586625","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21586625","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-11-0184","doi":"https://doi.org/10.1158/1078-0432.ccr-11-0184","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-0184","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/17/13/4568/2300086/4568.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310758","display_name":"Kreftforeningen","ror":"https://ror.org/01925vb10"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2136293754.pdf","grobid_xml":"https://content.openalex.org/works/W2136293754.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W1493822493","https://openalex.org/W1590412378","https://openalex.org/W1917632054","https://openalex.org/W1969137358","https://openalex.org/W1976636805","https://openalex.org/W1982403261","https://openalex.org/W1983954483","https://openalex.org/W1984955359","https://openalex.org/W1987294642","https://openalex.org/W1995541635","https://openalex.org/W2000856540","https://openalex.org/W2000971601","https://openalex.org/W2001740055","https://openalex.org/W2008667095","https://openalex.org/W2024794399","https://openalex.org/W2030976397","https://openalex.org/W2036032415","https://openalex.org/W2042122379","https://openalex.org/W2047902191","https://openalex.org/W2050300062","https://openalex.org/W2061365506","https://openalex.org/W2064507032","https://openalex.org/W2066738380","https://openalex.org/W2074516592","https://openalex.org/W2074904897","https://openalex.org/W2078805336","https://openalex.org/W2081521873","https://openalex.org/W2090247488","https://openalex.org/W2092728418","https://openalex.org/W2100158834","https://openalex.org/W2100745065","https://openalex.org/W2104788624","https://openalex.org/W2118544635","https://openalex.org/W2121276929","https://openalex.org/W2122476064","https://openalex.org/W2122951893","https://openalex.org/W2128313632","https://openalex.org/W2128591781","https://openalex.org/W2129104475","https://openalex.org/W2129146015","https://openalex.org/W2134754781","https://openalex.org/W2137723371","https://openalex.org/W2139248078","https://openalex.org/W2148177811","https://openalex.org/W2154203858","https://openalex.org/W2154551867","https://openalex.org/W2157027442","https://openalex.org/W2158164503","https://openalex.org/W2160925670","https://openalex.org/W2165177643"],"related_works":["https://openalex.org/W2245072080","https://openalex.org/W2162807322","https://openalex.org/W4382344271","https://openalex.org/W2123291375","https://openalex.org/W4213305983","https://openalex.org/W2283790569","https://openalex.org/W2475999235","https://openalex.org/W2762019896","https://openalex.org/W2064507032","https://openalex.org/W2402900135"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,94,101,132,175,217,236],"study":[2],"is":[3,185,221,234],"a":[4,162],"proof-of-principle":[5],"trial":[6],"evaluating":[7],"toxicity,":[8],"immune":[9,33,108,133],"response,":[10],"and":[11,22,59,73,91,149,195,244],"clinical":[12,140,176],"response":[13,82,109,134,219],"in":[14,35,112],"melanoma":[15,52],"patients":[16,190],"after":[17,213],"combined":[18],"therapy":[19],"with":[20,48,158,224,253],"temozolomide":[21,58],"the":[23,246],"telomerase":[24],"peptide":[25],"vaccine":[26],"GV1001.":[27,60],"Our":[28],"previous":[29,225],"GV1001":[30,74,226],"trials":[31,227],"showed":[32],"responses":[34,177],"approximately":[36],"60%":[37],"of":[38,114,138,151,241,249],"lung":[39],"or":[40,54],"pancreatic":[41],"cancer":[42,251],"patients.":[43],"EXPERIMENTAL":[44],"DESIGN:":[45],"Twenty-five":[46],"subjects":[47,117],"advanced":[49],"stage":[50],"IV":[51],"(M1B":[53],"M1C)":[55],"received":[56],"concomitant":[57,229],"Temozolomide":[61],"was":[62,83,103,110],"administered":[63],"200":[64],"mg/m\u00b2":[65],"orally":[66],"for":[67],"5":[68,214],"days":[69],"every":[70],"fourth":[71],"week,":[72],"as":[75],"eight":[76],"injections":[77],"over":[78,180],"11":[79],"weeks.":[80],"Immune":[81],"evaluated":[84,116],"by":[85],"delayed":[86],"type":[87],"hypersensitivity,":[88],"T-cell":[89,122],"proliferation,":[90],"cytokine":[92,147],"assays.":[93],"immunologic":[95,218],"responders":[96],"continued":[97],"monthly":[98],"vaccination.":[99],"RESULTS:":[100],"treatment":[102,243],"well":[104],"tolerated.":[105],"A":[106],"GV1001-specific":[107],"shown":[111],"18":[113],"23":[115],"(78%).":[118],"Patients":[119],"developing":[120],"long-term":[121],"memory":[123],"survived":[124],"more":[125,197],"than":[126],"those":[127],"rapidly":[128],"losing":[129],"their":[130],"responses.":[131],"exhibited":[135],"several":[136],"characteristics":[137],"possible":[139],"significance":[141],"including":[142],"high":[143],"IFN\u03b3/IL-10":[144],"ratios,":[145],"polyfunctional":[146],"profiles,":[148],"recognition":[150],"naturally":[152],"processed":[153],"antigens.":[154],"Survival":[155],"compared":[156,223],"favorably":[157],"matched":[159],"controls":[160],"from":[161,187],"benchmark":[163],"meta-analysis":[164],"(1":[165],"year:":[166],"44%":[167],"vs.":[168,173],"24%,":[169],"2":[170],"years:":[171],"16%":[172],"6.6%).":[174],"developed":[178,191],"gradually":[179],"years,":[181],"contrary":[182],"to":[183],"what":[184],"expected":[186],"chemotherapy.":[188,254],"Five":[189],"partial":[192],"tumor":[193],"regression":[194],"six":[196],"recorded":[198],"stable":[199],"disease.":[200],"One":[201],"patient":[202],"has":[203],"no":[204],"remaining":[205],"disease":[206],"on":[207],"fluorodeoxyglucose":[208],"positron":[209],"emission":[210],"tomography":[211],"scans":[212],"years.":[215],"CONCLUSIONS:":[216],"rate":[220],"considerable":[222],"without":[228],"chemotherapy,":[230],"although":[231],"low":[232],"toxicity":[233],"retained.":[235],"results":[237],"warrant":[238],"further":[239],"studies":[240],"GV1001/temozolomide":[242],"support":[245],"general":[247],"concept":[248],"combining":[250],"vaccination":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2136293754","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
